The Kronenberg Lab

RT @OliverVarhelyi: Insightful exchange with @fhpatienteurope. Around 90 million Europeans live with inherited lipid disorders – yet 98% of…

RT @fhpatienteurope: This morning - Don’t miss! #EASCongress2025 if you are “an Lp(a) addict” like Prof. Kronenberg! See you at 10:30GMT i…

@ProfSNicholls @TheLancet @lamcardio @richardhorton1 @dukenus @MonashVHI It is good to see this group of great experts

Excited to launch @TheLancet Commission on Finding Solutions for the Cardiovascular Disease Burden in the Asia Pacific Region with my good friend @lamcardio - a lot of work lies ahead with energetic colleagues @richardhorton1 @dukenus @MonashVHI

@RenateSchreibe1 @SamiaMoraMD @nationallipid @dan_soffer @CBallantyneMD @imed_tweets @lipiddoc @society_eas Vielen Dank, Renate

1/4 Feeling deeply honored to have received the Honorary Lifetime Membership Award from the US-based National Lipid Association (NLA) together with @SamiaMoraMD & Laurence Sperling. @nationallipid @dan_soffer @CBallantyneMD @imed_tweets @lipiddoc @society_eas @lpaITF @measurelpa

4/4 I also appreciate the support of the International Lp(a) Task Force I am priviledged to chair aiming that Lp(a) testing becomes the norm across the globe and that Lp(a) is managed equitably to contribute towards the prevention of cardiovascular disease. @lpaITF @measurelpa

3/4 Grateful to my team at our institute (they are the basis for the award), the Medical University of Innsbruck, our collaboration partners, and the European Atherosclerosis Society Lp(a) Consensus panel which I chaired together with @SamiaMoraMD & Erik Stroes.

RT @DineshKalra: #NLA2024 honors its dedicated and passionate lipid specialists who are fighting the good fight to combat dyslipidemia and…

RT @FedericaFogacci: What do current guidelines / statements say about Lp(a) & why did I also take the opportunity to test it? 😎#EASCongres…

1st of the @EASCongress in Lyon, France & the 1st time we’re so numerous with Patient Ambassadors, plus having a booth at the congress. Delighted to receive so much interest & to be connecting in person with great supporters, advisors & friends! Thank you for paying a visit!

RT @LaleTokgozoglu: Young fellows of the EAS together with plenary speakers during #EASCongress 2024 .I am so proud of them.What a great gr…

RT @azinkh96: As always, #AAS-Meeting was fabulous. Reuniting with other groups working on #atherosclerosis from all over Austria. P.S. Th…

We show in this first large prospective study that high apoA-IV levels are associated with reduced frequencies of history of cancer and incident fatal/non-fatal cancer events in >5000 patients with chronic kidney disease #apoA4 #apoA-IV #cancer #CKD See: t.ly/HCEur

RT @ATHjournal: Thanks to the whole community for being so interactive yesterday 💐! Even if the #LpaAwarenessDay is over, our commitment in…

RT @DrMarthaGulati: A4: #LpaAwarenessDay #KnowLpa Who should have their Lp(a) tested? EVERYONE!!!!!! #CVPrev #CardioTwitter #HeartHealth…

RT @fhpatienteurope: Today we support Lp(a) Awareness Day. Elevated Lp(a) can affect anyone, from any background, age or gender. It's an in…

RT @fhpatienteurope: Know your numbers! Lp(a) is considered high >50 mg/dL or 125 nmol/L. Do not mix up the units! High Lp(a) is an indepen…

Newest mtDNA GWAS: Happy to share our newest GWAS on mitochondrial DNA copy number in 16,130 samples from three studies were analyzed in our laboratory. Our PhD student Adriana Koller did an outstanding job to finish this demanding project. See more: nature.com/articles/s4159…

Happy to share our newest GWAS on PCSK9 which has been published open access in Atherosclerosis. We identified 5 novel loci for PCSK9 concentrations. See more: atherosclerosis-journal.com/article/S0021-… #PCSK9 #Atherosclerosis @society_eas @azinkh96 @ATHjournal @imed_tweets